» Articles » PMID: 12507502

Resistin Release by Human Adipose Tissue Explants in Primary Culture

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2003 Jan 1
PMID 12507502
Citations 66
Authors
Affiliations
Soon will be listed here.
Abstract

Resistin, also known as Fizz3 or ADSF, is a protein found in murine adipose tissue and inflammatory lung exudates. The present studies found that resistin was released by explants of human adipose tissue but the release was quite variable ranging from 3 to 158 ng/g over 48 h. The release of resistin was 250% greater by explants of omental than by explants of human subcutaneous abdominal adipose tissue. Resistin release by adipocytes was negligible as compared to that by the non-fat cells of adipose tissue. Leptin formation by adipocytes was 8-fold greater than its formation by the non-fat cells, while the formation of PAI-1 by adipocytes was 38% of that by the non-fat cells. The conversion of glucose to lactate as well as the formation of PGE(2) and IL-8 was approximately 15% of that by the non-fat cells. In contrast the release of IL-6 and IL-1beta by adipocytes was 4-7% of that by the non-fat cells while the formation of resistin and IL-10 by adipocytes was 2% of that by non-fat cells. The release of adiponectin by explants ranged from 1000 to 5000 ng/g over 48 h but did not correlate with that of resistin. The present data suggest that resistin release by explants of human adipose tissue in primary culture is largely derived from the non-fat cells present in the explants.

Citing Articles

Resistin concentrations in perivascular adipose tissue as a highly sensitive marker of smoking status in patients with advanced coronary artery disease requiring coronary artery bypass grafting.

Rachwalik M, Sarelo P, Obremska M, Matusiewicz M, Sett K, Czapla M Front Public Health. 2024; 12:1484195.

PMID: 39635208 PMC: 11614759. DOI: 10.3389/fpubh.2024.1484195.


Influence of Adipokines on Metabolic Dysfunction and Aging.

Park S, Shimokawa I Biomedicines. 2024; 12(4).

PMID: 38672227 PMC: 11048512. DOI: 10.3390/biomedicines12040873.


Circulatory resistin levels in inflammatory bowel disease: a systematic review and meta-analysis.

Behnoush A, Parmis Maroufi S, Reshadmanesh T, Kia Y, Norouzi M, Mohammadi S BMC Gastroenterol. 2024; 24(1):107.

PMID: 38486190 PMC: 10941394. DOI: 10.1186/s12876-024-03199-7.


Resistin-like molecules: a marker, mediator and therapeutic target for multiple diseases.

Shi Y, Zhu N, Qiu Y, Tan J, Wang F, Qin L Cell Commun Signal. 2023; 21(1):18.

PMID: 36691020 PMC: 9869618. DOI: 10.1186/s12964-022-01032-w.


ADSCs stimulated by resistin promote breast cancer cell malignancy via CXCL5 in a breast cancer coculture model.

Wang Y, Hung A, Wu Y, Lo S, Chen H, Chen Y Sci Rep. 2022; 12(1):15437.

PMID: 36104403 PMC: 9475041. DOI: 10.1038/s41598-022-19290-6.